Titan Medical Inc (TMDIF)

[renovatio33]

I'm not implying anything. I'm stating that with the max raise (not including an overallotment), Titan would need an additional $10m to get to the end of Q3. It's spelled out in the filing.

Funding is the biggest obstacle, especially on the OTCs. There is no control over what the market may do, nor can we predict how all trials will go, or what competitors may do, regulatory changes, etc. Anything negative would impact our ability to raise capital. Titan is in a great place today and there is a tremendous amount of interest which makes it easier to raise capital. There is downside in the dilutive nature, but this mitigates the future risk of funding. It's a smart move by management despite everyone's hurt feelings. Also, if Titan uplists within the next several months, the value proposition will be much better to institutional investors if we have a runway of cash as opposed to needing to do an imminent raise.

To your point regarding clinical success, demand should be higher, yes, but at that point there should be nothing keeping the share price from running higher if we don't need more cash immediately.

WIN-WIN

L&S